These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 31206354)

  • 21. Gaps in naloxone ownership among people who inject drugs during the fentanyl wave of the opioid overdose epidemic in New York City, 2018.
    Rivera AV; Nolan ML; Paone D; Carrillo SA; Braunstein SL
    Subst Abus; 2022; 43(1):1172-1179. PubMed ID: 35617642
    [No Abstract]   [Full Text] [Related]  

  • 22. Perceptions about fentanyl-adulterated heroin and overdose risk reduction behaviors among persons seeking treatment for heroin use.
    Stein MD; Kenney SR; Anderson BJ; Bailey GL
    J Subst Abuse Treat; 2019 Sep; 104():144-147. PubMed ID: 31370978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of Fentanyl Overdose - Massachusetts, 2014-2016.
    Somerville NJ; O'Donnell J; Gladden RM; Zibbell JE; Green TC; Younkin M; Ruiz S; Babakhanlou-Chase H; Chan M; Callis BP; Kuramoto-Crawford J; Nields HM; Walley AY
    MMWR Morb Mortal Wkly Rep; 2017 Apr; 66(14):382-386. PubMed ID: 28406883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Young people who use drugs engaged in harm reduction programs in New York City: Overdose and other risks.
    Calvo M; MacFarlane J; Zaccaro H; Curtis M; Cabán M; Favaro J; Passannante MR; Frost T
    Drug Alcohol Depend; 2017 Sep; 178():106-114. PubMed ID: 28645060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of take-home naloxone in the epidemic of opioid overdose involving illicitly manufactured fentanyl and its analogs.
    Kim HK; Connors NJ; Mazer-Amirshahi ME
    Expert Opin Drug Saf; 2019 Jun; 18(6):465-475. PubMed ID: 31033357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Social network support and harm reduction activities in a peer researcher-led pilot study, British Columbia, Canada.
    Elkhalifa S; Jozaghi E; Marsh S; Thomson E; Gregg D; Buxton J; Jolly A
    Harm Reduct J; 2020 Aug; 17(1):57. PubMed ID: 32825836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioid overdose in the age of fentanyl: Risk factor differences among subpopulations of overdose survivors.
    Kline A; Mattern D; Cooperman N; Williams JM; Dooley-Budsock P; Foglia R; Borys S
    Int J Drug Policy; 2021 Apr; 90():103051. PubMed ID: 33321284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expanding harm reduction to include fentanyl urine testing: results from a pilot in rural British Columbia.
    Mema SC; Sage C; Popoff S; Bridgeman J; Taylor D; Corneil T
    Harm Reduct J; 2018 Apr; 15(1):19. PubMed ID: 29625621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substance use patterns, sociodemographics, and health profiles of harm reduction service recipients in Burlington, Vermont.
    Erath TG; LaCroix R; O'Keefe E; Higgins ST; Rawson RA
    Harm Reduct J; 2024 Apr; 21(1):76. PubMed ID: 38580997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in drug use behaviors that impact overdose risk among individuals who do and do not use fentanyl test strips for drug checking.
    Tilhou AS; Zaborek J; Baltes A; Salisbury-Afshar E; Malicki J; Brown R
    Harm Reduct J; 2023 Mar; 20(1):41. PubMed ID: 36978170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "I don't want to die": a qualitative study of coping strategies to prevent fentanyl-related overdose deaths among people who inject drugs and its implications for harm reduction policies.
    Abadie R
    Harm Reduct J; 2023 Jun; 20(1):75. PubMed ID: 37316884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. I Don't Believe a Person Has to Die When Trying to Get High: Overdose Prevention and Response Strategies in Rural Illinois.
    Walters SM; Felsher M; Frank D; Jaiswal J; Townsend T; Muncan B; Bennett AS; Friedman SR; Jenkins W; Pho MT; Fletcher S; Ompad DC
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heroin and fentanyl overdoses in Kentucky: Epidemiology and surveillance.
    Slavova S; Costich JF; Bunn TL; Luu H; Singleton M; Hargrove SL; Triplett JS; Quesinberry D; Ralston W; Ingram V
    Int J Drug Policy; 2017 Aug; 46():120-129. PubMed ID: 28735777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada.
    Strike C; Watson TM
    Int J Drug Policy; 2019 Sep; 71():178-182. PubMed ID: 30975595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A fentanyl test strip intervention to reduce overdose risk among female sex workers who use drugs in Baltimore: Results from a pilot study.
    Park JN; Tomko C; Silberzahn BE; Haney K; Marshall BDL; Sherman SG
    Addict Behav; 2020 Nov; 110():106529. PubMed ID: 32683172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
    Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
    Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using Surveillance With Near-Real-Time Alerts During a Cluster of Overdoses From Fentanyl-Contaminated Crack Cocaine, Connecticut, June 2019.
    Canning P; Doyon S; Ali S; Logan SB; Alter A; Hart K; Coler R; Kamin R; Wolf SC; Soto K; Whiteman L; Jenkins M
    Public Health Rep; 2021; 136(1_suppl):18S-23S. PubMed ID: 34726975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized clinical trial of a theory-based fentanyl overdose education and fentanyl test strip distribution intervention to reduce rates of opioid overdose: study protocol for a randomized controlled trial.
    Jacka BP; Goldman JE; Yedinak JL; Bernstein E; Hadland SE; Buxton JA; Sherman SG; Biello KB; Marshall BDL
    Trials; 2020 Nov; 21(1):976. PubMed ID: 33243291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada.
    Papamihali K; Yoon M; Graham B; Karamouzian M; Slaunwhite AK; Tsang V; Young S; Buxton JA
    Harm Reduct J; 2020 Nov; 17(1):90. PubMed ID: 33228676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
    Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
    Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.